The economics of osteoporosis prevention

D J Torgerson, T Gosden, D M Reid

Research output: Contribution to journalLiterature reviewpeer-review

Abstract

Until recently, it was generally assumed that the prevention of a significant proportion of osteoporotic fractures could only be achieved through the use of hormone replacement therapy soon after menopause. It is likely to be most cost-effective, however, if antifracture therapy could be undertaken among older, higher risk populations. Recent evidence suggests that there are a number of effective interventions that can be used among the over-65 age group, and the economic evidence supports the view that this is likely to be the best way forward for fracture prevention. (C) 1997, Elsevier Science Inc.

Original languageEnglish
Pages (from-to)236-239
Number of pages4
JournalTrends in Endocrinology and Metabolism
Volume8
Issue number6
Publication statusPublished - Aug 1997

Keywords

  • HORMONE REPLACEMENT THERAPY
  • COST-EFFECTIVENESS ANALYSIS
  • BONE-MINERAL DENSITY
  • HIP FRACTURE
  • ELDERLY WOMEN
  • POSTMENOPAUSAL OSTEOPOROSIS
  • VITAMIN-D
  • RISK
  • ESTROGEN
  • TRIAL

Cite this